Login / Signup

Periodically repeated rituximab administrations in children with refractory nephrotic syndrome: 2-year multicenter observational study.

Toshiyuki TakahashiTakayuki OkamotoYasuyuki SatoTakeshi YamazakiAsako HayashiHayato AoyagiMichihiko UenoNorio KobayashiKimiaki UetakeMasanori NakanishiTadashi Ariga
Published in: Pediatric nephrology (Berlin, Germany) (2018)
Our protocol was useful and safe for refractory NS. However, RTX administration four times might have been excessive in patients who had no relapse by 1 year after the initial RTX administration. Further investigation of the most appropriate method of RTX administration is required.
Keyphrases
  • randomized controlled trial
  • young adults
  • dengue virus
  • zika virus
  • hodgkin lymphoma
  • chronic lymphocytic leukemia